𝔖 Bobbio Scriptorium
✦   LIBER   ✦

9077 Phase 2 study of pemetrexed and cisplatin plus either enzastaurin or placebo in chemonaive patients with advanced NSCLC

✍ Scribed by Reck, M.; Ramlau, R.; VonPawel, J.; Antonio, B. San; Visseren-Grul, C.; Chouaki, N.; Eschbach, C.; Szczesna, A.; Vansteenkiste, J.

Book ID
122727890
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
51 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

9164 An indirect comparison of the effic
9164 An indirect comparison of the efficacy of bevacizumab plus cisplatin and gemcitabine (BCG) or bevacizumab plus carboplatin and paclitaxel (BCP) versus pemetrexed plus cisplatin (PC) and cetuximab plus vinorelbine and cisplatin (CVC) in patients (pts) with advanced or recurrent non-small cell cancer (NSCLC)
✍ Walzer, S.; de Castro Carpeno, J.; Vergnenegre, A.V.; Chouaid, C.; Heigener, D.F πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 48 KB